<DOC>
	<DOCNO>NCT00893230</DOCNO>
	<brief_summary>The aim study assess clinical effect Lactobacillus sakei supplementation child atopic dermatitis .</brief_summary>
	<brief_title>A Study Probiotic Atopic Dermatitis</brief_title>
	<detailed_description>Probiotics also show reduce severity AEDS administer infant early onset AEDS . In contrast , study evaluate therapeutic effectiveness probiotic group old child establish AEDS . In study , administration Lactobacillus strain unselected child age 1 year associate improvement clinical severity eczema . The purpose study evaluate clinical efficacy AEDS newly identify probiotic strain , Lactobacillus sakei KCTC 10755BP , show potent inhibitory activity S aureus growth among Lactobacillus specie preliminary experiment . We administer L sakei unselected group child age 2 10 year moderate severe AEDS evaluate clinical outcome end intervention . In addition , also measure level serum chemokines activity marker AEDS provide objective evidence beneficial role probiotic .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>patient atopic dermatitis present least 6 month inclusion total SCORAD score 25 change total SCORAD score 10 % within 2 week patient treated cyclosporine , systemic steroid , topical calcineurin inhibitor , Chinese herbal medicine precede 3 month</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>atopic dermatitis</keyword>
	<keyword>chemokines</keyword>
	<keyword>probiotic</keyword>
</DOC>